Induced hypothermia is the only therapy with proven efficacy to reduce brain damage after perinatal asphyxia. While hypothermia down-regulates global protein synthesis and cell metabolism, low temperature induces a small subset of proteins that includes the RNA-binding protein RBM3 (RNA-binding motif protein 3), which has recently been implicated in cell survival. Here, immunohistochemistry of the developing postnatal murine brain revealed a spatio-temporal neuronal RBM3 expression pattern very similar to that of doublecortin, a marker of neuronal precursor cells. Mild hypothermia (32°C) profoundly promoted RBM3 expression and rescued neuronal cells from forced apoptosis as studied in primary neurons, PC12 cells, and cortical organotypic slice cultures. Blocking RBM3 expression in neuronal cells by specific siRNAs significantly diminished the neuroprotective effect of hypothermia while vector-driven RBM3 over-expression reduced cleavage of PARP, prevented internucleosomal DNA fragmentation, and LDH release also in the absence of hypothermia. Together, neuronal RBM3 up-regulation in response to hypothermia apparently accounts for a substantial proportion of hypothermia-induced neuroprotection.
Introduction
The only available therapy for neonatal asphyxia is cooling the infant's body to about 33°C (mild hypothermia) for 48-72 h. A series of randomized multicenter trials have established a protective effect of therapeutic hypothermia in reducing long-term sequelae (Edwards et al., 2010; Jacobs et al., 2007; Schulzke et al., 2007; Shah et al., 2007) .
Hypoxic-ischemic brain damage following asphyxia occurs in a biphasic manner, where the early phase (first hours) is classified as necrosis and the later phase (by 48 h) display characteristics of neuronal apoptosis (Northington et al., 2001a (Northington et al., , 2001b . Thus, the primary target of hypothermia is the mitigation of early cell death and the prevention of delayed neuronal apoptosis (Robertson et al., 2009) .
In neurons, hypoxia-ischemia triggers an intrinsic apoptotic pathway (Ferrand-Drake and Wieloch, 1999; Perez-Pinzon et al., 1999; Zhu et al., 2003) , characterized by a biochemical cascade leading to activation of caspases, cleavage of poly ADP-ribose polymerase (PARP), internucleosomal DNA fragmentation, and eventually cell death with release of intracellular enzymes, such LDH (Liu et al., 1996; Susin et al., 1999a Susin et al., , 1999b . Hypothermia ultimately appears to stop cell death (Edwards et al., 1995; Fukuda et al., 2001; Han et al., 2002; Zhu et al., 2004 ) but the precise molecular events of how and where hypothermia retards this biochemical cascade are poorly understood.
The RNA-binding protein RBM3 belongs to a very small group of cold inducible proteins being synthesized in response to either hypothermia or other conditions of mild stress (Lleonart, 2010) . RBM3 is evolutionary highly conserved (Derry et al., 1995) and has been suggested to play a role in hibernation (Fedorov et al., 2009; Williams et al., 2005) . While a temperature drop from 37 to 32-34°C is sufficient to induce the expression of RBM3 (Danno et al., 1997) , elevated temperature decreases the expression of RBM3 in the setting of therapeutic hyperthermia (Zeng et al., 2009 ) and in cryptorchid Neurobiology of Disease 43 (2011) 388-396 
